Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian
Clinical trial NCT04741828 · COMPLETED
Trial details
- NCT number
- NCT04741828
- Sponsor
- PT Bio Farma
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-03
- Primary completion
- 2024-10-28
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.